Clinical trials - Press Releases

Date	Title	Company
13-Jul-2021	New three-year data from the long-term extension of the STELARA® Phase 3 UNIFI study presented at ECCO 2021	Janssen Cilag ltd
12-Jul-2021	bluebird bio Announces Positive Recommendation by PRAC Regarding Article 20 Safety Referral Review of ZYNTEGLO ™ Gene Therapy for Transfusion-Dependent β-thalassaemia and Marketing to Resume in EU	bluebird bio
09-Jul-2021	Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia	Avance Clinical
09-Jul-2021	Global COVID-19 Clinical Trials Market 2021-2028 \|Moderna Inc, GlaxoSmithKline plc; Pfizer Inc, Johnson & Johnsona, INOVIO Pharmaceuticals, AbbVie Inc	infinitybusinessinsights
08-Jul-2021	Autoimmune Disease Diagnosis Market Size, Share, Growth Strategies, Trends and Forecast to 2025	MarketsandMarkets Research Private Ltd.
08-Jul-2021	Growing Use of Biomarkers in Drug Discovery and Cancer Biomarkers Market Development	Markets and Markets
08-Jul-2021	Moderna Announces First Participant Dosed in Phase 1/2 Study of Its Quadrivalent Seasonal Flu mRNA Vaccine	Moderna
08-Jul-2021	Parexel Expands Asia/Pacific Capability through Enhanced Clinical Trial Supplies and Logistics Offering	Parexel
08-Jul-2021	Tezepelumab regulatory submission accepted and granted FDA Priority Review in the US for the treatment of patients with asthma	AstraZeneca
07-Jul-2021	Technological Advancements in In Vitro Toxicology Testing Market and Business Developments	Markets and Markets
07-Jul-2021	Visiongain Publishes Cardiac Safety Services Market Report Up to 2031	Visiongain
06-Jul-2021	Arbutus Biopharma and Vaccitech Announce Clinical Trial Collaboration Agreement to Evaluate RNAi Therapeutic, AB-729, in Combination with Immunotherapeutic, VTP-300, in Subjects with Chronic Hepatitis B Virus Infection	Arbutus Biopharma and Vaccitech
06-Jul-2021	HUTCHMED Initiates Phase I Trials of novel ERK inhibitor HMPL 295 in Patients with Advanced Solid Tumors in China	HUTCHMED
06-Jul-2021	First Patient Dosed with Gadeta’s gamma delta TCR Cell Therapy	Gadeta
06-Jul-2021	PCSK9 Inhibitors Market is estimated to be US$ XX million by 2030 with a CAGR of x.x% during the forecast period	Prophecy Market Insights
06-Jul-2021	Sit less, move more: New studies shows low-to-moderate activity levels can significantly improve quality of life after bowel cancer	World Cancer Research Fund
05-Jul-2021	Annex 1 and Its Impact on Cleanrooms: Six Sessions Released at SMi’s Pharmaceutical Cleanroom Conference	SMi Group
02-Jul-2021	Immunoassay Market Drives Growth in the Biotechnology & Biopharmaceutical Industries	Markets and Markets
01-Jul-2021	163% growth in recruiting clinical trial sites in China, and no signs of slowing, Phesi analysis finds	Phesi Inc.
01-Jul-2021	AstraZeneca’s investigational MPO inhibitor AZD4831 shows promise in patients with heart failure and a preserved ejection fraction	AstraZeneca